Dementia Clinical Trial
Official title:
A Feasibility Study of a Psychosocial Intervention - The Talking Sense Communication Programme for Dementia Family Carers
Do family carers of people with dementia benefit from communication therapy and training?
This study will only involve carers of people with dementia. Nearly all people with dementia
will experience some difficulty communicating. Family carers of people with dementia have
described communication and associated behaviour difficulties as one of the hardest to cope
with.
This is a PhD study. The student/investigator has previously produced a detailed manual of
approaches for supporting relatives of people with dementia who are experiencing
communication difficulties. Previously published communication guides by other authors do
not present research evidence.
Carers will be recruited to this study from the local NHS older person's mental health
service overseen by their relative's psychiatrist. Only family carers will be included.
Recruits will be randomly assigned to a treatment group or a control group. People in the
control group will receive treatment as usual. The carers will be seen at home or at an NHS
site if they prefer. The investigator and carer will work through the contents of the manual
together. The manual is designed to consider their knowledge, thinking, skills and
behaviour. The treatment will take no more than 4.5 hours over a period of up to 12 weeks.
Carers will be asked to complete questionnaires before and after the treatment. As well as
background information, these questionnaires will look for any significant effects of the
treatment on carers' anxiety and depression, carers' quality of life, carers' belief in
their ability to care, communication difficulties experienced and the carers perceptions of
their relatives communication competence.
A sample of 15 carers will also be interviewed by a third party interviewer who will be an
existing speech and language therapy employee of Solent NHS Trust (see attached job
description and person specification). The interviews will ask more specifically about their
thoughts, feelings and opinions of this intervention and their experience in addressing
communication difficulties.
This is a feasibility study that intends to recruit 60 family carers over a period of up to
4 years. Carers will remain in the study for up to 12 weeks. They will be randomly assigned
to a Talking Sense communication intervention and a treatment as usual control group of
equal size. Quantitative and qualitative outcomes will be measured. Measures will include
carer anxiety and depression, carer quality of life, carer general self efficacy and
communication specific self efficacy as well as the carers rating of their relative's
communication competence.
The null hypothesis for this study is that receiving the Talking Sense communication
intervention would have no effect on carer reported depression, carer quality of life,
carer's perception of their ability to cope with communication difficulties, carer reported
experience of communication difficulties and carer reported person with dementia's
communication competence. The alternative hypothesis suggests that one or more of these
outcomes would be significantly greater for the treatment group in comparison to the control
group.
This selection of outcome measures was identified by comparison with other treatment studies
and in keeping with a theoretical framework for carer intervention studies described in a
key text by Professor Richard Schulz, a prominent author in this field. Other longer term
measures such as time to institutionalisation would be valuable though considered outside
the remit of this study which is measuring short term effect only. If this feasibility study
leads to a larger study, the longitudinal or wearing off of treatment effect would also be
important to measure.
The ideal control group for this study would be carers receiving no treatment though this
would be unethical. Comparison to another form of treatment e.g. a leaflet has been used in
other studies though this introduces additional variables to account for. In this case
treatment as usual is considered to be the most appropriate form of control condition.
Carers will be invited to participate in this study by a nurse or psychiatrist from the
older person's mental health service. They will be asked if they wish to take a leaflet
which broadly explains the purpose of the study and if their contact details can be passed
to the chief investigator. All referrals will be approved by one of four overseeing
psychiatrists.
If in agreement, the carer will be telephoned by the chief investigator. Some carers may be
excluded if they do not meet the study criteria though still offered communication therapy
outside of the study if required.
During this telephone contact, the chief investigator will provide a summary of the research
study and answer any initial questions. If carers remain interested in participation, the
chief investigator will arrange to visit them at home or on an NHS site. Carers will be sent
a copy of the participant information sheet to read prior to this meeting.
At this first meeting, the carer will be given a copy of the participant information sheet
which will be read to them as much as required. They will be supported in understanding this
where necessary. If they are keen to participate, they will be invited to sign a consent
form. They will be offered time for consideration and a return visit/meeting if required.
After the carer has signed a consent form they will be provided with a set of questionnaires
to complete. Questionnaires will include a service receipt inventory and carer background
information. The form and process of completing these questionnaires will be explained to
them. They will then be asked to complete these questionnaires when alone. The chief
investigator will arrange to collect these questionnaires.
Carers will be randomly assigned to the treatment or control group using a list of randomly
generated numbers by a third party colleague employee of Solent NHS Trust.
Carers will be informed of their group assignment when the pre-treatment questionnaire packs
are collected.
Carers assigned to the treatment group will be asked about arranging future appointments.
They will then be sent a letter explaining what happens next including dates of agreed
appointments and when to expect delivery of the post treatment questionnaires. All carers
will be offered a telephone reminder to complete questionnaires if required.
Carers in both groups will continue to receive any support already planned from members of
the older person's mental health service. Carers in the control group will also receive
communication advice from the investigator in keeping with a model of treatment as usual.
Carers in both groups will complete a service receipt inventory in their post intervention
set of questionnaires.
Carers in both groups will be advised of when to expect delivery and collection of a second
post-intervention set of questionnaires. These will be collected.
The referrer and over-seeing psychiatrist will be informed of the carer's decision to
participate and assignment to treatment or control group.
Carers will be seen on 3 occasions for a maximum total time of 4.5 hours. All interventions
will be provided by the chief investigator.
Carers will be encouraged to be seen alone. Therapy sessions will be offered in their home
or at an NHS site.
Carers will be shown the Talking Sense manual and given an overview of the 9 steps that it
covers: knowledge, insight, thoughts and feelings, the environment, the person, how to be as
the carer, reminders and encouraging conversation, communication and activities and
challenging behaviours.
All treatment session will be audio recorded. Analysis of these recordings will be used to
measure the treatment provider's adherence as well as time spent on and most popular topics
of discussion. Carers will also be invited to make notes.
During the first session carers will be encouraged to grade their relative's degree of
communication difficulty using the grading scale incorporated into the Talking Sense
programme.
The investigator will also use display resources adapted from the Talking Sense manual to
explain specific issues.
For the second and third session the carers will be encouraged to select topics to discuss,
thoughts to consider and strategies to rehearse from the Talking Sense programme.
Suitability of topics will be guided by the grade of communication difficulty they
previously selected. There are five grades: very early, early, moderate, advanced and
severe. For example, the validation approach to communication in dementia is only suitable
for people with moderate, advanced or severe communication difficulties in dementia.
Within one week of the final treatment session, all treatment group carers will be sent a
1-2 page printed individualised summary of the topics and issues identified and discussed.
The study period will be 10 to 12 weeks for each carer. For those receiving the intervention
there will be at least a two week gap between receiving the summary document after the last
intervention session and completing the post intervention questionnaires and interview.
Between weeks 10 and 12, a purposive sample of approximately 15 carers from the intervention
group will be invited to participate in an interview. These will be conducted by a single
independent interviewer who will be an existing Speech and Language Therapy department
employee of Solent NHS Trust. This person will have been trained by the chief investigator
in using a semi-structured interview protocol. Carers will be asked to participate in an
interview, at a location of their choice (as above) lasting no longer than 60 minutes.
These interviews will be recorded and transcribed. The investigator will use a grounded
hermeneutic approach of analysis with constant comparison leading to the development of
themes and meta-themes. Consent to participate in the interview will be agreed with all
participants at the start of the study until all interviews are completed.
At the end of their participation, all participants will be sent a thank you letter. Carers
will also be able to request further advice and support if required.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05686486 -
Gentle Gymnastics and Relationship Between Family Caregivers and Residents With Dementia in Nursing Homes
|
N/A | |
| Terminated |
NCT05451693 -
Outreach-ER: A Dementia Care Intervention Program
|
||
| Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
| Enrolling by invitation |
NCT06040294 -
Dementia and Disability Simulation for College Nursing Students' Senior Activity Facilitation Skills
|
N/A | |
| Completed |
NCT05114187 -
An Internet-Based Education Program for Care Partners of People Living With Dementia
|
N/A | |
| Recruiting |
NCT06322121 -
Vascular Aspects in Dementia: Part 2
|
||
| Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Completed |
NCT04426838 -
Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad
|
N/A | |
| Recruiting |
NCT03462485 -
Pilot Study of the Effects of Playing Golf on People With Dementia
|
N/A | |
| Active, not recruiting |
NCT03677284 -
Managing Time With Dementia: Effects of Time Assistive Products in People With Dementia
|
N/A | |
| Completed |
NCT03849937 -
Changing Talk Online (CHATO) Study
|
N/A | |
| Recruiting |
NCT06284213 -
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
|
||
| Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
| Completed |
NCT05080777 -
Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems
|
N/A | |
| Completed |
NCT04571697 -
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
|
||
| Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
| Recruiting |
NCT06033066 -
Financial Incentives and Recruitment to the APT Webstudy
|
N/A | |
| Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
| Recruiting |
NCT05684783 -
Dementia Champions in Homecare
|
||
| Completed |
NCT03147222 -
Function Focused Care: Fracture Care at Home
|
N/A |